NuVasive Q3 Income at $7M, Up Nearly 250% From Last Year

NuVasive reported its consolidated net income in the third quarter of $7.3 million, up nearly 250 percent compared to the same period last year.

Advertisement

The company reported $169 million in total third quarter revenue, up 14 percent from the same period last year. Spine revenue also jumped this past quarter, up 16 percent to $131 million. Biologics and monitoring services experienced modest increases.

More Articles on Devices:
Device Companies — 7 Key Notes — Zimmer, Boston Scientific & More
Baxano Surgical Granted Patent for Visual Approach of Lateral Access Fusion System
Orthozon Technologies’ Lumiere Retractor System Recognized as Top Device for Spine

 

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.